Parexel

Today, on International Clinical Trials Day, we honor the incredible work that drives progress in global health. Clinical research isn't just about science, it's about people. The dedicated teams, innovative partners and inspiring patients who make breakthroughs possible. At Parexel, we're grateful for everyone who fuels this mission every single day. Our global colleagues who push boundaries. Our partners who collaborate with purpose. Our customers who trust us with their vision. And most importantly, patients who inspire us to accelerate the delivery of life-saving treatments. Watch our CEO Peyton Howell share why this day matters to all of us. 💙 #InternationalClinicalTrialsDay #ICTD2026 #ClinicalTrialsDay #CTD2026

Over the weekend, Parexel leaders and their families attended the Veterans Bridge Home's "Star Spangled Salute" Gala in Charlotte, NC. This annual event raises funds to support local veterans, service members and their families through advocacy and building connections. At Parexel, we are committed to supporting the military through our Military Community Business Resource Group (BRG). Founded in 2023, this BRG is focused on ensuring veterans and spouses can thrive and feel supported in their careers. The group now includes 300+ members including veterans, spouses, their family members and supporters.

Speed in clinical trials only matters if it’s reliable – and proven. ParexelAI™ is already delivering measurable impact across clinical development: 🔹 50% reduction in site selection process timelines 🔹 30% reduction in clinical study report preparation time in medical writing 🔹 20% efficiency gains in safety literature review and case processing By eliminating manual bottlenecks and improving workflow efficiency, ParexelAI helps teams move faster without compromising quality. Explore what faster, more predictable delivery could look like: https://lnkd.in/eNqj4NJy #ParexelAI

Patient centricity is a popular point of discussion but how can we turn that talk into action that helps patients? On the latest episode of ACRO's Good Clinical Podcast, Parexel's Chief Patient Officer Stacy Hurt 🌻 joined Medidata Solutions' Alicia C. Staley to discuss the gap between discussing patient centricity and putting it into action. So, what does it take to put patients first? It all starts with strengthening partnerships with patient advocacy communities and elevating patients as leaders so their care plans can truly meet their needs. Listen wherever you get your podcasts: https://brnw.ch/21x2D31

Ophthalmology innovation is accelerating, with personalized medicine, forward-looking evidence generation, advanced diagnostics, AI-enabled research and evolving stakeholder expectations reshaping the future of development. In this special event edition of the New Medicines, Novel Insights newsletter, we're reflecting on key themes emerging from the 2026 ARVO Annual Meeting, from biomarker-driven and personalized approaches to the growing role of advanced technologies in ophthalmology research and development. Across conversations at ARVO, one message came through clearly: future success will depend on clinical development strategies designed not just for today’s landscape, but for evolving treatment paradigms still to come. Read the full article to explore what these trends could mean for the future of ophthalmology development. #ARVO #ARVO2026 #Ophthalmology #ClinicalDevelopment #PrecisionMedicine

⭐Our CEO Peyton Howell recently joined fellow Triangle Business Journal 2026 Life Sciences Award honorees to celebrate individuals and organizations for being trailblazers across the industry. 🌃It was a fantastic evening connecting with leaders who are shaping the future of life sciences. Parexel is proud to have been named the Most Innovative Clinical Research Organization, among such accomplished peers.

Advancing clinical development today requires more than incremental change; it requires a new model for delivery.   Introducing ParexelAI™. A proprietary suite of AI services and capabilities designed to help not only accelerate timelines but also unlock the ability to run more programs simultaneously across a global network.   By combining deep scientific and regulatory expertise with AI-enabled delivery, ParexelAI helps bring greater speed, quality and efficiency to every stage of development, with one goal in mind: getting treatments to patients sooner.   Discover how ParexelAI is reshaping clinical development: https://lnkd.in/eNqj4NJy #ParexelAI #AIinClinicalResearch #AI

🚀 We're excited to introduce ParexelAI™, an innovative, proprietary suite of human-led AI services and capabilities that power Parexel operations and deliver greater speed, quality and efficiency to customers and, ultimately, patients. ParexelAI combines our proprietary tools, internal innovation, strategic partnerships and expertise of our 22,000+ global team members — all while prioritizing human judgment, scientific and regulatory expertise, and patient safety. Because every efficiency gained serves our mission: accelerating the delivery of life-changing treatments to patients. Learn more: https://brnw.ch/21x2AD8 Read the full announcement: https://brnw.ch/21x2AD9

From AI and clinical trial agility to policy and innovation, the discussions from the Financial Times US Pharma & Biotech Summit reinforced one thing: meaningful progress happens when strategy, science and execution come together. We were proud to contribute to the conversation through two impactful sessions: Rob Goodwin, Chief Operating Officer, shared his perspective in a keynote interview on building a patient-first culture. He highlighted how embedding patient-centricity at the core of operations can drive better outcomes, faster enrollment and stronger performance across development programs. Tala Fakhouri, Ph.D., M.P.H., Chief AI & Regulatory Strategy Officer, joined the panel 𝘈𝘐 𝘪𝘯 𝘗𝘩𝘢𝘳𝘮𝘢 – 𝘈 𝘵𝘪𝘮𝘦 𝘵𝘰 𝘥𝘦𝘭𝘪𝘷𝘦𝘳, focusing on how the industry can move beyond experimentation to real, scalable impact across the clinical trial lifecycle. It was exciting to be part of the discussion shaping how the industry will continue to advance innovation, accelerate development and deliver for patients. #FTPharma #FTPharmaAndBiotechSummit

In honor of National Cancer Research Month, Stacy Hurt 🌻, Chief Patient Officer, sat down with Jozsef Palatka, MD, Senior Vice President, Global Therapeutic Area Head, Oncology, for May's internal #PatientsFirstFridays session with Parexel colleagues. Jozsef highlights a critical shift: designing trials that reduce burden, respect patients’ lives and treat them as true partners. Their perspectives are essential to shaping better research. He also shares a key opportunity to transform oncology trials—moving beyond linear models to more flexible, hybrid approaches powered by real-world data and digital innovation, making research more patient-focused. Watch the clip to learn more. #NationalCancerResearchMonth